AIM Thanks House for Bipartisan Commitment to Alzheimer's Disease Research Funding
WASHINGTON, D.C., July 6, 2016 - The Alzheimer's Impact Movement (AIM) commends the House Labor-HHS Appropriations Subcommittee for its proposed $350 million increase for Alzheimer's disease research...
Hope for Alzheimer's Act's Medicare Benefit Proposed at CMS
WASHINGTON, D.C., July 12, 2016 - Today the Alzheimer's Impact Movement (AIM) joined the Alzheimer's Association and advocates across the country in commending Congress and the Centers for Medicare &...
AIM Honors Governors Walker (R-WI) and Markell (D-DE) with Trailblazer Award
WASHINGTON, D.C., July 26, 2016 - The Alzheimer's Impact Movement (AIM) presented Governor Scott Walker of Wisconsin and Governor Jack Markell of Delaware with the 2016 AIM Trailblazer Award. The...
AIM Supports Senator Blunt's Re-Election for His Commitment in the Fight to End Alzheimer's
WASHINGTON, D.C., October 29, 2016 - In appreciation and acknowledgement of Senator Roy Blunt's (R-MO) continued leadership in the fight to end Alzheimer's, the Alzheimer's Impact Movement (AIM) is...
AIM Thanks Senator Murray for Her Commitment in the Fight to End Alzheimer's
WASHINGTON, D.C., October 29, 2016 - In recognition and appreciation of Senator Patty Murray's (D-WA) efforts in the fight to end Alzheimer's the Alzheimer's Impact Movement (AIM) is supporting her re...
Medicare to Pay for Cognitive Assessment and Care Planning for Persons with Alzheimer's Disease
WASHINGTON, D.C., November 3, 2016 - The Alzheimer's Impact Movement (AIM) is celebrating the final decision by the Centers for Medicare & Medicaid Services (CMS) to improve access to care and support...
WASHINGTON, D.C., December 7, 2016 - Following action taken by the House of Representatives, the Senate today voted to pass the 21st Century Cures Act, which would secure additional funding at the...
Bipartisan Legislation Will Strengthen the Nation's Commitment to Addressing Alzheimer's
The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support the bipartisan NAPA Reauthorization Act and the Alzheimer's Accountability and Investment Act. Introduced in...
Pathway to Treatments Through Accelerated Approvals
This week, the Alzheimer's Association sponsored, and the Hill hosted, a discussion on accelerated approval with policymakers, experts and patient advocates. Through the Food and Drug Administration's...
Securing Critical Funding for Alzheimer’s and Other Dementia Research
Earlier this month, a $289 million increase in funding for Alzheimer's and other dementia research at the National Institutes of Health (NIH) was approved by Congress and signed into law by President...